

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.16305280 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.91683166 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.82912495 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.59114871 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.40264854 |
| 6 | vocalization behavior (GO:0071625) | 5.25245793 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.18854916 |
| 8 | protein localization to synapse (GO:0035418) | 5.16418903 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.03884381 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.80554909 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.79623522 |
| 12 | glutamate secretion (GO:0014047) | 4.67079758 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.66862866 |
| 14 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.65637331 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.64796496 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.62820853 |
| 17 | central nervous system myelination (GO:0022010) | 4.51202953 |
| 18 | axon ensheathment in central nervous system (GO:0032291) | 4.51202953 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.39549286 |
| 20 | glutamate receptor signaling pathway (GO:0007215) | 4.30627825 |
| 21 | positive regulation of synapse maturation (GO:0090129) | 4.28792834 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.24272784 |
| 23 | exploration behavior (GO:0035640) | 4.23344461 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 4.16983290 |
| 25 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.13346142 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.13054604 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 3.97503825 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 3.95929028 |
| 29 | cellular potassium ion homeostasis (GO:0030007) | 3.95894405 |
| 30 | positive regulation of membrane potential (GO:0045838) | 3.94950959 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.92661133 |
| 32 | neurotransmitter secretion (GO:0007269) | 3.88328471 |
| 33 | neuronal ion channel clustering (GO:0045161) | 3.88319667 |
| 34 | amino acid import (GO:0043090) | 3.87025412 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 3.85585043 |
| 36 | regulation of synapse structural plasticity (GO:0051823) | 3.83014813 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.81941100 |
| 38 | long-term memory (GO:0007616) | 3.81880387 |
| 39 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.78740634 |
| 40 | rhodopsin mediated signaling pathway (GO:0016056) | 3.75388361 |
| 41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.70567412 |
| 42 | sodium ion export (GO:0071436) | 3.68746160 |
| 43 | membrane hyperpolarization (GO:0060081) | 3.67373026 |
| 44 | retinal cone cell development (GO:0046549) | 3.64995427 |
| 45 | synaptic vesicle endocytosis (GO:0048488) | 3.62180433 |
| 46 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.56300632 |
| 47 | gamma-aminobutyric acid transport (GO:0015812) | 3.55671551 |
| 48 | dendrite morphogenesis (GO:0048813) | 3.53536178 |
| 49 | axonal fasciculation (GO:0007413) | 3.51267388 |
| 50 | innervation (GO:0060384) | 3.49699443 |
| 51 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.48655169 |
| 52 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.46967875 |
| 53 | * neuron recognition (GO:0008038) | 3.46456077 |
| 54 | urinary tract smooth muscle contraction (GO:0014848) | 3.44246921 |
| 55 | postsynaptic membrane organization (GO:0001941) | 3.42307697 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.41185428 |
| 57 | regulation of synapse maturation (GO:0090128) | 3.40408810 |
| 58 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.40012130 |
| 59 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.39495347 |
| 60 | detection of light stimulus involved in visual perception (GO:0050908) | 3.39495347 |
| 61 | regulation of synaptic plasticity (GO:0048167) | 3.36255566 |
| 62 | negative regulation of dendrite development (GO:2000171) | 3.35683808 |
| 63 | response to pheromone (GO:0019236) | 3.33624788 |
| 64 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.32497237 |
| 65 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.31024528 |
| 66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.28998369 |
| 67 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.28806712 |
| 68 | establishment of mitochondrion localization (GO:0051654) | 3.28488863 |
| 69 | long-term synaptic potentiation (GO:0060291) | 3.28099105 |
| 70 | regulation of vesicle fusion (GO:0031338) | 3.27703523 |
| 71 | neurotransmitter transport (GO:0006836) | 3.27367643 |
| 72 | neuronal action potential propagation (GO:0019227) | 3.24553011 |
| 73 | startle response (GO:0001964) | 3.24308469 |
| 74 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.23748282 |
| 75 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.17480793 |
| 76 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.15001791 |
| 77 | positive regulation of action potential (GO:0045760) | 3.14778959 |
| 78 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.13415339 |
| 79 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.12895286 |
| 80 | cell communication by electrical coupling (GO:0010644) | 3.12831747 |
| 81 | membrane depolarization (GO:0051899) | 3.12470379 |
| 82 | neuromuscular process controlling balance (GO:0050885) | 3.12465609 |
| 83 | regulation of neurotransmitter levels (GO:0001505) | 3.12465234 |
| 84 | transmission of nerve impulse (GO:0019226) | 3.12247395 |
| 85 | response to auditory stimulus (GO:0010996) | 3.12037831 |
| 86 | proline transport (GO:0015824) | 3.11731475 |
| 87 | behavioral fear response (GO:0001662) | 3.10587881 |
| 88 | behavioral defense response (GO:0002209) | 3.10587881 |
| 89 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.10292679 |
| 90 | auditory behavior (GO:0031223) | 3.10092532 |
| 91 | nucleobase catabolic process (GO:0046113) | 3.08416970 |
| 92 | cerebellar granule cell differentiation (GO:0021707) | 3.07317324 |
| 93 | positive regulation of neurotransmitter transport (GO:0051590) | 3.06408416 |
| 94 | regulation of neurotransmitter transport (GO:0051588) | 3.05494976 |
| 95 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.04964905 |
| 96 | L-amino acid import (GO:0043092) | 3.04382070 |
| 97 | detection of calcium ion (GO:0005513) | 3.04319402 |
| 98 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.03310766 |
| 99 | presynaptic membrane assembly (GO:0097105) | 3.03111175 |
| 100 | positive regulation of dendritic spine development (GO:0060999) | 3.01452461 |
| 101 | photoreceptor cell development (GO:0042461) | 3.00668517 |
| 102 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.00554090 |
| 103 | membrane depolarization during action potential (GO:0086010) | 2.99704089 |
| 104 | chemosensory behavior (GO:0007635) | 2.98873681 |
| 105 | learning (GO:0007612) | 2.97326577 |
| 106 | regulation of ARF protein signal transduction (GO:0032012) | 2.96720414 |
| 107 | retinal rod cell development (GO:0046548) | 2.96551711 |
| 108 | cell migration in hindbrain (GO:0021535) | 2.96163903 |
| 109 | glycosphingolipid biosynthetic process (GO:0006688) | 2.95627305 |
| 110 | response to histamine (GO:0034776) | 2.95549000 |
| 111 | potassium ion homeostasis (GO:0055075) | 2.95251598 |
| 112 | presynaptic membrane organization (GO:0097090) | 2.93997029 |
| 113 | regulation of dendritic spine development (GO:0060998) | 2.93422348 |
| 114 | synapse assembly (GO:0007416) | 2.92681920 |
| 115 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91460360 |
| 116 | dopamine receptor signaling pathway (GO:0007212) | 2.90586984 |
| 117 | mechanosensory behavior (GO:0007638) | 2.85426968 |
| 118 | membrane assembly (GO:0071709) | 2.84040100 |
| 119 | righting reflex (GO:0060013) | 2.80374534 |
| 120 | potassium ion import (GO:0010107) | 2.76956908 |
| 121 | cAMP-mediated signaling (GO:0019933) | 2.76924728 |
| 122 | negative regulation of axonogenesis (GO:0050771) | 2.75058808 |
| 123 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.73309876 |
| 124 | adult walking behavior (GO:0007628) | 2.73185279 |
| 125 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.70580870 |
| 126 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.70310782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.28186804 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.23673184 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.94625088 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.94318035 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.82157596 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69147308 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.63227052 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.63227052 |
| 9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60933487 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54865773 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50040385 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49126884 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47642370 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43641169 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41469696 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.37352361 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.36952238 |
| 18 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.32784268 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25501218 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.25258004 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.15445235 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.09514127 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09513397 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08166918 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.03665468 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.95066833 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.91607574 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86615649 |
| 29 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71584750 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.68044017 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67493451 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56389198 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52292910 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52031810 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.48112093 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47018735 |
| 37 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46379545 |
| 38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.41026921 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40254227 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39600876 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38636180 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38030383 |
| 43 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.35109888 |
| 44 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32944933 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31480956 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28328735 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25437644 |
| 48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24463021 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23454658 |
| 50 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23262537 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22734610 |
| 52 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22535614 |
| 53 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22283967 |
| 54 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20915258 |
| 55 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20486433 |
| 56 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18225061 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17487056 |
| 58 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16216041 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16028937 |
| 60 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15627034 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15392193 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13290693 |
| 63 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11445667 |
| 64 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11257377 |
| 65 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10547228 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10545963 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08385464 |
| 68 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06267087 |
| 69 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06101705 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05399615 |
| 71 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05164471 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04894016 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04769170 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04463407 |
| 75 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03574789 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03152714 |
| 77 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02219010 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01452894 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01296030 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00921287 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00835641 |
| 82 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00519756 |
| 83 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99599653 |
| 84 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99438720 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99142262 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99142262 |
| 87 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99061519 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98721729 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98090491 |
| 90 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.97944905 |
| 91 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97183208 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97148451 |
| 93 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96977074 |
| 94 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96769769 |
| 95 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96298403 |
| 96 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94010536 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92182796 |
| 98 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.91640108 |
| 99 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91585241 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91123225 |
| 101 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90557215 |
| 102 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.90276646 |
| 103 | * ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90089400 |
| 104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89308386 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88601825 |
| 106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87203528 |
| 107 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.86963847 |
| 108 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.86794127 |
| 109 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.86469195 |
| 110 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84910181 |
| 111 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84442529 |
| 112 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83982893 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83490208 |
| 114 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.82353594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.49013520 |
| 2 | MP0003880_abnormal_central_pattern | 4.54705913 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 3.84500264 |
| 4 | MP0005551_abnormal_eye_electrophysiolog | 3.51366352 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.42943261 |
| 6 | MP0004270_analgesia | 3.30116685 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.14761074 |
| 8 | MP0009745_abnormal_behavioral_response | 3.04423193 |
| 9 | MP0002064_seizures | 2.93695682 |
| 10 | MP0009046_muscle_twitch | 2.76430905 |
| 11 | MP0001486_abnormal_startle_reflex | 2.55817057 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.55155454 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.53897165 |
| 14 | MP0002272_abnormal_nervous_system | 2.51982148 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.37816043 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.29258741 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 2.21105328 |
| 18 | MP0005253_abnormal_eye_physiology | 2.11930977 |
| 19 | MP0000778_abnormal_nervous_system | 2.11845823 |
| 20 | MP0002822_catalepsy | 1.93903027 |
| 21 | MP0001984_abnormal_olfaction | 1.93551613 |
| 22 | MP0002736_abnormal_nociception_after | 1.92477939 |
| 23 | MP0002184_abnormal_innervation | 1.92290432 |
| 24 | MP0008569_lethality_at_weaning | 1.92259231 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.88592493 |
| 26 | MP0004885_abnormal_endolymph | 1.82657721 |
| 27 | MP0003011_delayed_dark_adaptation | 1.81398571 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.77815407 |
| 29 | MP0004858_abnormal_nervous_system | 1.76743767 |
| 30 | * MP0002882_abnormal_neuron_morphology | 1.75850242 |
| 31 | MP0001502_abnormal_circadian_rhythm | 1.74617571 |
| 32 | MP0003787_abnormal_imprinting | 1.72174355 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.71446073 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.69930206 |
| 35 | MP0001970_abnormal_pain_threshold | 1.66599706 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.65038380 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.61243223 |
| 38 | MP0000955_abnormal_spinal_cord | 1.58554349 |
| 39 | MP0002229_neurodegeneration | 1.57933741 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.55974827 |
| 41 | MP0003329_amyloid_beta_deposits | 1.48359449 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.46513403 |
| 43 | MP0004924_abnormal_behavior | 1.46513403 |
| 44 | MP0002090_abnormal_vision | 1.46250366 |
| 45 | MP0009780_abnormal_chondrocyte_physiolo | 1.45359869 |
| 46 | MP0005646_abnormal_pituitary_gland | 1.43632629 |
| 47 | MP0003879_abnormal_hair_cell | 1.43532097 |
| 48 | * MP0005195_abnormal_posterior_eye | 1.39346578 |
| 49 | MP0001346_abnormal_lacrimal_gland | 1.35825243 |
| 50 | MP0002066_abnormal_motor_capabilities/c | 1.34184696 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.33824210 |
| 52 | * MP0002752_abnormal_somatic_nervous | 1.30651118 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.26481249 |
| 54 | MP0001348_abnormal_lacrimal_gland | 1.26050620 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.22992600 |
| 56 | MP0004510_myositis | 1.19603226 |
| 57 | MP0002152_abnormal_brain_morphology | 1.17266801 |
| 58 | MP0006292_abnormal_olfactory_placode | 1.16970560 |
| 59 | MP0005394_taste/olfaction_phenotype | 1.16176661 |
| 60 | MP0005499_abnormal_olfactory_system | 1.16176661 |
| 61 | MP0003633_abnormal_nervous_system | 1.16118668 |
| 62 | MP0002638_abnormal_pupillary_reflex | 1.15464832 |
| 63 | MP0004742_abnormal_vestibular_system | 1.13720285 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.11925336 |
| 65 | MP0004142_abnormal_muscle_tone | 1.05264881 |
| 66 | MP0003634_abnormal_glial_cell | 1.04363146 |
| 67 | MP0004043_abnormal_pH_regulation | 1.03335090 |
| 68 | MP0003631_nervous_system_phenotype | 1.03036283 |
| 69 | MP0003122_maternal_imprinting | 0.98267504 |
| 70 | MP0006276_abnormal_autonomic_nervous | 0.98033268 |
| 71 | MP0000569_abnormal_digit_pigmentation | 0.96281084 |
| 72 | MP0001963_abnormal_hearing_physiology | 0.94555866 |
| 73 | MP0001177_atelectasis | 0.92451501 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 0.91959782 |
| 75 | MP0002069_abnormal_eating/drinking_beha | 0.90733582 |
| 76 | MP0000920_abnormal_myelination | 0.89203631 |
| 77 | MP0008872_abnormal_physiological_respon | 0.86581473 |
| 78 | MP0005391_vision/eye_phenotype | 0.86008454 |
| 79 | MP0001529_abnormal_vocalization | 0.83659332 |
| 80 | MP0003632_abnormal_nervous_system | 0.82914459 |
| 81 | MP0003075_altered_response_to | 0.81351808 |
| 82 | MP0001324_abnormal_eye_pigmentation | 0.78078583 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.76470004 |
| 84 | MP0004145_abnormal_muscle_electrophysio | 0.75269505 |
| 85 | MP0001905_abnormal_dopamine_level | 0.74481274 |
| 86 | MP0001188_hyperpigmentation | 0.73565333 |
| 87 | MP0008874_decreased_physiological_sensi | 0.72997948 |
| 88 | MP0008789_abnormal_olfactory_epithelium | 0.72651853 |
| 89 | MP0003861_abnormal_nervous_system | 0.71320608 |
| 90 | MP0005535_abnormal_body_temperature | 0.70358128 |
| 91 | MP0004233_abnormal_muscle_weight | 0.69717061 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.68552517 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.68429168 |
| 94 | MP0004085_abnormal_heartbeat | 0.66890982 |
| 95 | MP0010386_abnormal_urinary_bladder | 0.66598411 |
| 96 | MP0001943_abnormal_respiration | 0.66343463 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.65596075 |
| 98 | MP0008877_abnormal_DNA_methylation | 0.64908806 |
| 99 | MP0002254_reproductive_system_inflammat | 0.64510514 |
| 100 | MP0001944_abnormal_pancreas_morphology | 0.63783455 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.63731668 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.63436900 |
| 103 | MP0003121_genomic_imprinting | 0.62673231 |
| 104 | * MP0002082_postnatal_lethality | 0.61919208 |
| 105 | * MP0010770_preweaning_lethality | 0.61919208 |
| 106 | MP0000026_abnormal_inner_ear | 0.61457447 |
| 107 | * MP0010769_abnormal_survival | 0.61103031 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.60785985 |
| 109 | MP0000604_amyloidosis | 0.60265914 |
| 110 | MP0003690_abnormal_glial_cell | 0.60235105 |
| 111 | MP0004133_heterotaxia | 0.59273089 |
| 112 | MP0003119_abnormal_digestive_system | 0.57928666 |
| 113 | * MP0010768_mortality/aging | 0.57728723 |
| 114 | MP0003123_paternal_imprinting | 0.56573914 |
| 115 | MP0002234_abnormal_pharynx_morphology | 0.54670203 |
| 116 | MP0005409_darkened_coat_color | 0.53999723 |
| 117 | MP0000516_abnormal_urinary_system | 0.53594345 |
| 118 | MP0005367_renal/urinary_system_phenotyp | 0.53594345 |
| 119 | MP0003283_abnormal_digestive_organ | 0.53290143 |
| 120 | MP0004130_abnormal_muscle_cell | 0.52123292 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.50458415 |
| 122 | MP0003938_abnormal_ear_development | 0.50279637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 7.26192640 |
| 2 | Focal motor seizures (HP:0011153) | 6.17377187 |
| 3 | Myokymia (HP:0002411) | 5.93274991 |
| 4 | Central scotoma (HP:0000603) | 5.04922836 |
| 5 | Focal seizures (HP:0007359) | 4.64615175 |
| 6 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.64250932 |
| 7 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.57336547 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.53343197 |
| 9 | Visual hallucinations (HP:0002367) | 4.36854880 |
| 10 | Abnormality of macular pigmentation (HP:0008002) | 4.23724687 |
| 11 | Febrile seizures (HP:0002373) | 4.13836160 |
| 12 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.06633917 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 4.06106590 |
| 14 | Scotoma (HP:0000575) | 3.91656858 |
| 15 | Decreased central vision (HP:0007663) | 3.77525062 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.41148875 |
| 17 | Ankle clonus (HP:0011448) | 3.38336620 |
| 18 | Action tremor (HP:0002345) | 3.34764436 |
| 19 | Absence seizures (HP:0002121) | 3.27092605 |
| 20 | Pendular nystagmus (HP:0012043) | 3.24432815 |
| 21 | Severe visual impairment (HP:0001141) | 3.23335179 |
| 22 | Atonic seizures (HP:0010819) | 3.09181002 |
| 23 | Chorioretinal atrophy (HP:0000533) | 3.05697045 |
| 24 | Dialeptic seizures (HP:0011146) | 3.01162302 |
| 25 | Genetic anticipation (HP:0003743) | 2.98213251 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 2.96821790 |
| 27 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.93083045 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.92868558 |
| 29 | Abnormal ciliary motility (HP:0012262) | 2.92330016 |
| 30 | Broad-based gait (HP:0002136) | 2.89889285 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 2.88329548 |
| 32 | Pigmentary retinal degeneration (HP:0001146) | 2.87767352 |
| 33 | Dysdiadochokinesis (HP:0002075) | 2.87457406 |
| 34 | Absent/shortened dynein arms (HP:0200106) | 2.84990697 |
| 35 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.84990697 |
| 36 | Dyschromatopsia (HP:0007641) | 2.84427640 |
| 37 | Abnormality of the lower motor neuron (HP:0002366) | 2.83073442 |
| 38 | Attenuation of retinal blood vessels (HP:0007843) | 2.80591460 |
| 39 | Abolished electroretinogram (ERG) (HP:0000550) | 2.80080656 |
| 40 | Depression (HP:0000716) | 2.79148700 |
| 41 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.77028286 |
| 42 | Poor eye contact (HP:0000817) | 2.73589488 |
| 43 | Dysmetria (HP:0001310) | 2.73524542 |
| 44 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.68476681 |
| 45 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.68476681 |
| 46 | Hepatoblastoma (HP:0002884) | 2.65507758 |
| 47 | Truncal ataxia (HP:0002078) | 2.63333928 |
| 48 | Hyperventilation (HP:0002883) | 2.62919129 |
| 49 | Spastic gait (HP:0002064) | 2.60954560 |
| 50 | Mutism (HP:0002300) | 2.58823335 |
| 51 | Akinesia (HP:0002304) | 2.56200892 |
| 52 | Polyphagia (HP:0002591) | 2.56095598 |
| 53 | Increased circulating renin level (HP:0000848) | 2.55714221 |
| 54 | Drooling (HP:0002307) | 2.55452325 |
| 55 | Excessive salivation (HP:0003781) | 2.55452325 |
| 56 | Macular degeneration (HP:0000608) | 2.54623788 |
| 57 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.54299587 |
| 58 | Abnormality of the corticospinal tract (HP:0002492) | 2.52397497 |
| 59 | Postural instability (HP:0002172) | 2.48086655 |
| 60 | Abnormal social behavior (HP:0012433) | 2.47304009 |
| 61 | Impaired social interactions (HP:0000735) | 2.47304009 |
| 62 | Photophobia (HP:0000613) | 2.46945041 |
| 63 | Choroideremia (HP:0001139) | 2.46714232 |
| 64 | Type II diabetes mellitus (HP:0005978) | 2.44735539 |
| 65 | Hemiparesis (HP:0001269) | 2.34242161 |
| 66 | Oligodactyly (hands) (HP:0001180) | 2.33729728 |
| 67 | Protruding tongue (HP:0010808) | 2.32973782 |
| 68 | Urinary urgency (HP:0000012) | 2.31450183 |
| 69 | Amblyopia (HP:0000646) | 2.31300382 |
| 70 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.31155687 |
| 71 | Anxiety (HP:0000739) | 2.30668772 |
| 72 | Increased corneal curvature (HP:0100692) | 2.29697925 |
| 73 | Keratoconus (HP:0000563) | 2.29697925 |
| 74 | Sleep apnea (HP:0010535) | 2.25102829 |
| 75 | Neurofibrillary tangles (HP:0002185) | 2.23859524 |
| 76 | Absent speech (HP:0001344) | 2.23051083 |
| 77 | Peripheral hypomyelination (HP:0007182) | 2.22152794 |
| 78 | Intention tremor (HP:0002080) | 2.19836136 |
| 79 | Epileptiform EEG discharges (HP:0011182) | 2.19354328 |
| 80 | Lower limb muscle weakness (HP:0007340) | 2.17290423 |
| 81 | Rhinitis (HP:0012384) | 2.15684299 |
| 82 | Thickened helices (HP:0000391) | 2.15359187 |
| 83 | Torticollis (HP:0000473) | 2.13915338 |
| 84 | Abnormality of the labia minora (HP:0012880) | 2.13690019 |
| 85 | EEG with generalized epileptiform discharges (HP:0011198) | 2.13511026 |
| 86 | Progressive inability to walk (HP:0002505) | 2.12648615 |
| 87 | Hemiplegia (HP:0002301) | 2.10689278 |
| 88 | Alacrima (HP:0000522) | 2.10197798 |
| 89 | Cone-rod dystrophy (HP:0000548) | 2.09694710 |
| 90 | Impaired smooth pursuit (HP:0007772) | 2.09450229 |
| 91 | Scanning speech (HP:0002168) | 2.09167420 |
| 92 | Widely spaced teeth (HP:0000687) | 2.08039039 |
| 93 | Status epilepticus (HP:0002133) | 2.05968992 |
| 94 | Gait imbalance (HP:0002141) | 2.03525926 |
| 95 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.01622968 |
| 96 | Focal dystonia (HP:0004373) | 1.99056460 |
| 97 | Stereotypic behavior (HP:0000733) | 1.98988592 |
| 98 | Hypsarrhythmia (HP:0002521) | 1.97889199 |
| 99 | Cerebral inclusion bodies (HP:0100314) | 1.96934515 |
| 100 | Insomnia (HP:0100785) | 1.94805574 |
| 101 | Abnormal eating behavior (HP:0100738) | 1.94677447 |
| 102 | Abnormality of binocular vision (HP:0011514) | 1.94383724 |
| 103 | Diplopia (HP:0000651) | 1.94383724 |
| 104 | Split foot (HP:0001839) | 1.93698459 |
| 105 | Clonus (HP:0002169) | 1.92992662 |
| 106 | Megalencephaly (HP:0001355) | 1.92840603 |
| 107 | Obstructive sleep apnea (HP:0002870) | 1.92697289 |
| 108 | Bradykinesia (HP:0002067) | 1.90808208 |
| 109 | Retinitis pigmentosa (HP:0000510) | 1.90550599 |
| 110 | Esotropia (HP:0000565) | 1.89805027 |
| 111 | Impaired vibratory sensation (HP:0002495) | 1.88310447 |
| 112 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.85971763 |
| 113 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.85971763 |
| 114 | Hyperaldosteronism (HP:0000859) | 1.84741380 |
| 115 | Amyotrophic lateral sclerosis (HP:0007354) | 1.84449666 |
| 116 | Papilledema (HP:0001085) | 1.83849902 |
| 117 | Pointed chin (HP:0000307) | 1.83017451 |
| 118 | Septo-optic dysplasia (HP:0100842) | 1.82706932 |
| 119 | Abnormality of the periventricular white matter (HP:0002518) | 1.82641777 |
| 120 | Specific learning disability (HP:0001328) | 1.81845638 |
| 121 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81102791 |
| 122 | Spastic tetraplegia (HP:0002510) | 1.80881128 |
| 123 | Fetal akinesia sequence (HP:0001989) | 1.76506350 |
| 124 | Posterior subcapsular cataract (HP:0007787) | 1.75381756 |
| 125 | Retinal dysplasia (HP:0007973) | 1.75179370 |
| 126 | Prolonged QT interval (HP:0001657) | 1.73168772 |
| 127 | Limb dystonia (HP:0002451) | 1.72775810 |
| 128 | Hypoplasia of the corpus callosum (HP:0002079) | 1.72688261 |
| 129 | Ventricular fibrillation (HP:0001663) | 1.72112050 |
| 130 | Agitation (HP:0000713) | 1.72072657 |
| 131 | Nephronophthisis (HP:0000090) | 1.71749129 |
| 132 | Abnormal drinking behavior (HP:0030082) | 1.70841972 |
| 133 | Polydipsia (HP:0001959) | 1.70841972 |
| 134 | Cerebral hypomyelination (HP:0006808) | 1.69762824 |
| 135 | Decreased lacrimation (HP:0000633) | 1.69557518 |
| 136 | Generalized myoclonic seizures (HP:0002123) | 1.69138631 |
| 137 | Hypomagnesemia (HP:0002917) | 1.68595493 |
| 138 | Intellectual disability, severe (HP:0010864) | 1.66856521 |
| 139 | Gastroesophageal reflux (HP:0002020) | 1.64662261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.69666567 |
| 2 | NTRK3 | 4.14181409 |
| 3 | MARK1 | 4.03883523 |
| 4 | MAP3K9 | 3.12705043 |
| 5 | FRK | 2.84146040 |
| 6 | PAK6 | 2.64651719 |
| 7 | MAP3K4 | 2.57118134 |
| 8 | MINK1 | 2.26570535 |
| 9 | PRPF4B | 2.12429330 |
| 10 | NTRK2 | 2.09185349 |
| 11 | KSR2 | 2.07502928 |
| 12 | FGFR2 | 2.06057858 |
| 13 | MAP2K7 | 2.04754592 |
| 14 | DAPK2 | 2.01165244 |
| 15 | PRKD3 | 1.99105523 |
| 16 | KSR1 | 1.78185361 |
| 17 | SIK2 | 1.75733171 |
| 18 | CASK | 1.71820188 |
| 19 | CAMKK1 | 1.70994045 |
| 20 | TNIK | 1.58712125 |
| 21 | CDK5 | 1.53087799 |
| 22 | MAP3K13 | 1.43247571 |
| 23 | SGK223 | 1.40992731 |
| 24 | SGK494 | 1.40992731 |
| 25 | MAPK13 | 1.38401905 |
| 26 | STK38 | 1.38371101 |
| 27 | PHKG2 | 1.35734631 |
| 28 | PHKG1 | 1.35734631 |
| 29 | FES | 1.35425526 |
| 30 | MAP2K4 | 1.23019233 |
| 31 | NTRK1 | 1.21395151 |
| 32 | PKN1 | 1.12974598 |
| 33 | WNK3 | 1.12787179 |
| 34 | TYRO3 | 1.12390156 |
| 35 | RIPK4 | 1.10376359 |
| 36 | PRKCG | 1.03143122 |
| 37 | SGK2 | 1.02617879 |
| 38 | DYRK1A | 1.02210766 |
| 39 | GRK5 | 1.01859337 |
| 40 | PINK1 | 1.01286933 |
| 41 | PLK2 | 0.99738812 |
| 42 | CAMK1 | 0.99655561 |
| 43 | DYRK2 | 0.99345990 |
| 44 | GRK1 | 0.97419833 |
| 45 | CAMK2A | 0.97290218 |
| 46 | PAK3 | 0.96728380 |
| 47 | DAPK1 | 0.93296322 |
| 48 | STK11 | 0.92884944 |
| 49 | UHMK1 | 0.92762910 |
| 50 | ARAF | 0.91050665 |
| 51 | MAP3K2 | 0.90345883 |
| 52 | RAF1 | 0.89530532 |
| 53 | CAMK1G | 0.88477503 |
| 54 | MAPK15 | 0.87321371 |
| 55 | SGK1 | 0.86127990 |
| 56 | SGK3 | 0.85669130 |
| 57 | MAP3K7 | 0.84157024 |
| 58 | CDK15 | 0.82117565 |
| 59 | CDK18 | 0.81942834 |
| 60 | CAMK2B | 0.81394762 |
| 61 | ICK | 0.81321287 |
| 62 | BCR | 0.81075628 |
| 63 | CDK19 | 0.78753071 |
| 64 | PNCK | 0.77965031 |
| 65 | MARK2 | 0.77946897 |
| 66 | PRKCH | 0.77592097 |
| 67 | PRKCZ | 0.74834216 |
| 68 | CAMK4 | 0.73668554 |
| 69 | CDK14 | 0.73030775 |
| 70 | CDC42BPA | 0.70870880 |
| 71 | CDK11A | 0.69849661 |
| 72 | MAP4K2 | 0.69731067 |
| 73 | NEK6 | 0.67884073 |
| 74 | PTK2B | 0.65252416 |
| 75 | CAMKK2 | 0.64653577 |
| 76 | ERBB3 | 0.64508283 |
| 77 | BMPR2 | 0.63809622 |
| 78 | RET | 0.63699206 |
| 79 | TAOK1 | 0.63438466 |
| 80 | ALK | 0.62966202 |
| 81 | ROCK2 | 0.62577920 |
| 82 | MAPK12 | 0.59796365 |
| 83 | RPS6KA3 | 0.57956786 |
| 84 | ERBB2 | 0.56414117 |
| 85 | CSNK1G2 | 0.55540832 |
| 86 | CAMK2D | 0.54891650 |
| 87 | PRKCE | 0.54036830 |
| 88 | CSNK1D | 0.53118088 |
| 89 | EPHA3 | 0.52470355 |
| 90 | WNK1 | 0.51861859 |
| 91 | DMPK | 0.51778842 |
| 92 | RIPK1 | 0.51453731 |
| 93 | TAOK2 | 0.49948322 |
| 94 | MAPK10 | 0.49202888 |
| 95 | NME1 | 0.48760539 |
| 96 | CCNB1 | 0.48538886 |
| 97 | CSNK1A1L | 0.47903733 |
| 98 | CDK3 | 0.47106722 |
| 99 | PRKG1 | 0.45985060 |
| 100 | CSNK1A1 | 0.45721574 |
| 101 | MAP3K12 | 0.44355758 |
| 102 | OXSR1 | 0.44261862 |
| 103 | ROCK1 | 0.43927073 |
| 104 | TNK2 | 0.43527959 |
| 105 | PRKCB | 0.43066985 |
| 106 | FYN | 0.42395155 |
| 107 | MAPK8 | 0.41474342 |
| 108 | PDK1 | 0.41036819 |
| 109 | RPS6KA2 | 0.40945192 |
| 110 | GSK3B | 0.40865139 |
| 111 | INSRR | 0.40529829 |
| 112 | FER | 0.40076136 |
| 113 | MAP2K6 | 0.39758816 |
| 114 | CAMK1D | 0.39075825 |
| 115 | BRD4 | 0.38474324 |
| 116 | MAP3K1 | 0.38025168 |
| 117 | AKT3 | 0.37963388 |
| 118 | LMTK2 | 0.37754955 |
| 119 | CAMK2G | 0.37458248 |
| 120 | PRKAA1 | 0.37365367 |
| 121 | FGFR3 | 0.35934301 |
| 122 | RPS6KB1 | 0.34235667 |
| 123 | PRKACA | 0.33080627 |
| 124 | CSNK1G3 | 0.31416664 |
| 125 | PRKD1 | 0.29437258 |
| 126 | CSNK1G1 | 0.28842579 |
| 127 | CDK12 | 0.28192417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 4.35430456 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.52773735 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.10143374 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.84450262 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.80398792 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.67773320 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61183464 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.59641162 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.51017579 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.23382401 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.01273787 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.00107740 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.96231801 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91728439 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.89085737 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.80923831 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68041397 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63318337 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62459904 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62402444 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49012934 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.48999361 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47287300 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.46005371 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.45347329 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44134061 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38607634 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32530575 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.30083938 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28376816 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26372852 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15943137 |
| 33 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14302161 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11173684 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10720538 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.08728010 |
| 37 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06359985 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.03677087 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02691952 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.02033447 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97509886 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94049937 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94048238 |
| 44 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90797801 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90706299 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90149643 |
| 47 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.89564702 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89366162 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 0.87856705 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87454922 |
| 51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83779550 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83366059 |
| 53 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83287358 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80551208 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78935548 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77408537 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75308172 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.74891156 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72509516 |
| 60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71385732 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70196953 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68949946 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68519601 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67087883 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65482660 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64927042 |
| 67 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64209757 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62282563 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61982674 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61867164 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61589047 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60361203 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59351441 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58388889 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55979359 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55460337 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55036973 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54953580 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54780453 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54463705 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54236791 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52559728 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51732024 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.51307626 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51060301 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49760858 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49555311 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.49039962 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48547178 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43860479 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43179170 |
| 92 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43127303 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42996658 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42917901 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42221782 |
| 96 | Alcoholism_Homo sapiens_hsa05034 | 0.42186251 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42035849 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42003159 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41886438 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39832750 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39270296 |
| 102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38802024 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38395329 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37931677 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36482777 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.35225204 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33961675 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.33597929 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32939785 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.31339466 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.26219421 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25920567 |
| 113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25435676 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25047830 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24877470 |

